MIM
Martin Investment Management Portfolio holdings
AUM
$390M
This Quarter Return
+9.63%
1 Year Return
+9.2%
3 Year Return
+57.18%
5 Year Return
+97.51%
10 Year Return
+265.79%
AUM
$407M
AUM Growth
+$407M
(+21%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
10.46%
Top 10 Holdings %
Top 10 Hldgs %
61.01%
Holding
49
New
1
Increased
12
Reduced
22
Closed
1
Top Buys
| 1 |
Haleon
HLN
|
$37.6M |
| 2 |
Toyota
TM
|
$1.39M |
| 3 |
Novo Nordisk
NVO
|
$1.2M |
| 4 |
Check Point Software Technologies
CHKP
|
$1.17M |
| 5 |
Gartner
IT
|
$1.03M |
Top Sells
| 1 |
Medtronic
MDT
|
$795K |
| 2 |
Bristol-Myers Squibb
BMY
|
$517K |
| 3 |
Mastercard
MA
|
$257K |
| 4 |
Apple
AAPL
|
$165K |
| 5 |
American Express
AXP
|
$137K |
Sector Composition
| 1 | Healthcare | 36.01% |
| 2 | Technology | 25.41% |
| 3 | Financials | 10.43% |
| 4 | Consumer Discretionary | 10.32% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Novo Nordisk
NVO
$251B
| $38.1M | 9.36% | 296,781 +9,315 | +3% | +$1.2M |
|
|
2
Haleon
HLN
$43.9B
| $37.9M | 9.31% | 4,463,205 +4,426,375 | +12,018% | +$37.6M |
|
|
3
Toyota
TM
$254B
| $30.8M | 7.56% | 122,230 +5,520 | +5% | +$1.39M |
|
|
4
Check Point Software Technologies
CHKP
$20.7B
| $27.2M | 6.67% | 165,581 +7,130 | +4% | +$1.17M |
|
5
Novartis
NVS
$245B
| $22.9M | 5.63% | 236,800 +10,665 | +5% | +$1.03M |
|
6
Alcon
ALC
$39.5B
| $22.5M | 5.53% | 270,352 +11,900 | +5% | +$991K |
|
|
7
Mastercard
MA
$538B
| $19.4M | 4.77% | 40,280 -533 | -1% | -$257K |
|
|
8
Apple
AAPL
$3.45T
| $18.6M | 4.57% | 108,417 -964 | -0.9% | -$165K |
|
9
Sony
SONY
$165B
| $18.3M | 4.5% | 213,620 +11,465 | +6% | +$983K |
|
10
Alphabet (Google) Class A
GOOGL
$2.57T
| $12.7M | 3.12% | 84,109 -877 | -1% | -$132K |
|
11
Berkshire Hathaway Class B
BRK.B
$1.09T
| $11.5M | 2.82% | 27,293 -308 | -1% | -$130K |
|
12
Booking.com
BKNG
$181B
| $10.6M | 2.61% | 2,927 -29 | -1% | -$105K |
|
|
13
American Express
AXP
$231B
| $10.3M | 2.54% | 45,433 -601 | -1% | -$137K |
|
14
Thermo Fisher Scientific
TMO
$186B
| $10.2M | 2.5% | 17,475 -97 | -0.6% | -$56.4K |
|
15
NXP Semiconductors
NXPI
$59.2B
| $8.18M | 2.01% | 33,002 +34 | +0.1% | +$8.42K |
|
16
Accenture
ACN
$162B
| $8.15M | 2% | 23,519 -326 | -1% | -$113K |
|
17
General Dynamics
GD
$87.3B
| $7.96M | 1.96% | 28,190 -205 | -0.7% | -$57.9K |
|
18
Stryker
SYK
$150B
| $7.96M | 1.96% | 22,237 -296 | -1% | -$106K |
|
19
Ametek
AME
$42.7B
| $7.84M | 1.93% | 42,890 +33 | +0.1% | +$6.04K |
|
20
Wabtec
WAB
$33.1B
| $7.65M | 1.88% | 52,515 -169 | -0.3% | -$24.6K |
|
21
Verisk Analytics
VRSK
$37.5B
| $7.49M | 1.84% | 31,765 -131 | -0.4% | -$30.9K |
|
22
Roper Technologies
ROP
$56.6B
| $7.12M | 1.75% | 12,698 +6 | +0% | +$3.37K |
|
23
L3Harris
LHX
$51.9B
| $6.95M | 1.71% | 32,609 -157 | -0.5% | -$33.5K |
|
24
Procter & Gamble
PG
$368B
| $6.8M | 1.67% | 41,915 -284 | -0.7% | -$46.1K |
|
25
Merck
MRK
$210B
| $6.38M | 1.57% | 48,338 +68 | +0.1% | +$8.97K |
|